Your browser doesn't support javascript.
loading
Giant gluteal and vesical plexiform neurofibromas in a patient with neurofibromatosis type 1: a case report.
Sassi, Imen; Bouida, Mohamed Amine; Hasnaoui, Anis; Zemni, Ines; Ben Dhieb, Tarek.
Afiliação
  • Sassi I; Surgical Oncology Department, Salah Azaiez Institute of Oncology, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia. imen.sassi.mail@gmail.com.
  • Bouida MA; Surgical Oncology Department, Salah Azaiez Institute of Oncology, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.
  • Hasnaoui A; Department of General Surgery, Menzel Bourguiba Hospital, Faculty of Medicine of Tunis, Tunis El Manar University, 7050, Menzel Bourguiba, Bizerta, Tunisia.
  • Zemni I; Surgical Oncology Department, Salah Azaiez Institute of Oncology, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.
  • Ben Dhieb T; Surgical Oncology Department, Salah Azaiez Institute of Oncology, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.
J Med Case Rep ; 18(1): 15, 2024 Jan 13.
Article em En | MEDLINE | ID: mdl-38216958
ABSTRACT

BACKGROUND:

Neurofibromatosis type 1 is a neurocutaneous genetic disorder caused by mutations in the NF1 gene, resulting in the formation of benign tumors called neurofibromas. The most common type of tumor seen in patients with neurofibromatosis type 1 is the slow-growing and benign neurofibroma, with a subtype called plexiform neurofibroma being particularly common and causing pain, functional impairment, and cosmetic disfigurement. CASE PRESENTATION We report the case of a 20-year-old North African female patient with a history of neurofibromatosis type 1 who presented with a growing mass in her right gluteal region, which was later diagnosed as a giant cutaneous neurofibroma. Imaging studies revealed infiltration in several regions, including the urinary bladder wall, resulting in significant bilateral hydronephrosis. The patient is currently being monitored, and no excisional procedures are planned.

CONCLUSIONS:

Neurofibromatosis type 1 can cause a variety of clinical symptoms, including the development of large plexiform neurofibromas. It is important to closely monitor patients with neurofibromatosis type 1 for the early detection of neurofibromas. Early detection and prompt surgical intervention are essential for preventing complications.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Neurofibromatose 1 / Neurofibroma Plexiforme / Neurofibroma Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Neurofibromatose 1 / Neurofibroma Plexiforme / Neurofibroma Idioma: En Ano de publicação: 2024 Tipo de documento: Article